Neuroprotective/Neurotrophic Effect of Lexapro in Patients With Posttraumatic Stress Disorder.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Escitalopram (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 06 Jun 2012 Planned End Date changed from 1 Jun 2011 to 1 Feb 2014 as reported by ClinicalTrials.gov.
- 10 Jan 2011 Planned End Date changed from 1 Nov 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 11 Nov 2009 New trial record